78.26
1.47 (1.91%)
| Penutupan Terdahulu | 76.79 |
| Buka | 77.93 |
| Jumlah Dagangan | 3,214 |
| Purata Dagangan (3B) | 6,874 |
| Modal Pasaran | 16,386,623,488 |
| Harga / Pendapatan (P/E TTM) | 14.69 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Oct 2025 |
| Hasil Dividen (DY TTM) | 1.08% |
| Margin Keuntungan | 11.31% |
| Margin Operasi (TTM) | -7.94% |
| EPS Cair (TTM) | 5.03 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 2.30% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 156.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 26.30% |
| Nisbah Semasa (MRQ) | 2.97 |
| Aliran Tunai Operasi (OCF TTM) | -9.56 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -23.91 M |
| Pulangan Atas Aset (ROA TTM) | 1.44% |
| Pulangan Atas Ekuiti (ROE TTM) | 10.19% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (GB) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | PHARMA MAR SA PHARMA MAR ORD SH | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 1.5 |
| Purata | 0.00 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| PHARMA MAR SA PHARMA MAR ORD SH | 16 B | 1.08% | 14.69 | - |
| ARROWHEAD PHARMACEUTICALS INC A | 4 B | - | - | - |
| GENUS PLC ORD 10P | 2 B | 0.01% | 81.55 | 3.61 |
| BASILEA PHARMACEUTICA AG BASILE | 511 M | - | - | 6.18 |
| AVACTA GROUP PLC ORD 10P | 353 M | - | - | 2.35 |
| PROTHENA CORPORATION PLC PROTHE | 330 M | - | 7.53 | - |
|
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 29.37% |
| % Dimiliki oleh Institusi | 8.67% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |